COVID-19 and Mycobacterium coinfection in Brunei Darussalam: case series

Authors

  • Babu Ivan Mani National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam
  • Panduru Venkata Kishore Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • Wai Yan Khine Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • Dilip Joseph Thottacherry Suri Seri Begawan Hospital, Belait, Brunei Darussalam
  • Pui Lin Chong National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam
  • Muhamad Syafiq Abdullah National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam
  • Rosmonaliza Asli National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam
  • Natalie Raimiza Momin National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • Noor Affizan Rahman National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam; Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • Chee Fui Chong National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam
  • Vui Heng Chong National Isolation Centre, Ministry of Health, Tutong, Brunei Darussalam; Pengiran Muda Mahkota Pengiran Muda Haji Al-Muhtadee Billah Hospital, Tutong, Brunei Darussalam; Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam

DOI:

https://doi.org/10.5365/wpsar.2023.14.3.1011

Keywords:

SARS-CoV-2, COVID-19, coinfection, mycobacterium tuberculosis, pulmonary tuberculosis, Brunei

Abstract

Coronavirus disease (COVID-19) and tuberculosis (TB) coinfection is expected to become more common in countries where TB is endemic, and coinfection has been reported to be associated with less favourable outcomes. Knowing about the manifestations and outcomes of coinfection is important as COVID-19 becomes endemic. During the second wave of the COVID-19 pandemic in Brunei Darussalam, we encountered seven patients with COVID-19 and Mycobacterium coinfection. Cases of coinfection included three patients with newly diagnosed pulmonary Mycobacterium infection (two cases of pulmonary TB [PTB] and one case of Mycobacterium fortuitum infection) and four patients who were already being treated for TB (three cases of PTB and one case of TB lymphadenitis). Among the new cases, one had previously tested negative for PTB during a pre-employment medical fitness evaluation and had defaulted from follow up and evaluation. One case died: a 42-year-old man with diabetes mellitus, chronic kidney disease and hypertension who had severe COVID-19 and needed urgent dialysis and supplemental oxygen. All other patients recovered from COVID-19 and completed their TB treatment.

Author Biography

Dilip Joseph Thottacherry, Suri Seri Begawan Hospital, Belait, Brunei Darussalam

Department of Medicine

Consultant

Downloads

Published

18-08-2023

How to Cite

1.
Mani BI, Kishore PV, Khine WY, Thottacherry DJ, Chong PL, Abdullah MS, Asli R, Momin NR, Rahman NA, Chong CF, Chong VH. COVID-19 and Mycobacterium coinfection in Brunei Darussalam: case series. Western Pac Surveill Response J [Internet]. 2023 Aug. 18 [cited 2026 Apr. 10];14(3). Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/1011

Issue

Vol. 14 No. 3 (2023): July ‒ September

Section

Case Report / Case Series

License

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

When the Licensor is an intergovernmental organization, disputes will be resolved by mediation and arbitration unless otherwise agreed.

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Most read articles by the same author(s)